Discover the Divis Labs Stock Liveblog, your go-to destination for real-time updates and comprehensive analysis of a top-performing stock. Keep track of Divis Labs's latest details, including: Last ...
Stay informed with the Divis Labs Stock Liveblog, your comprehensive resource for real-time updates and in-depth analysis of ...
Divis Laboratories is reporting earnings from the most recent quarter on August 8. Wall Street analysts predict earnings per share of INR 11.98. Follow Divis Laboratories stock price in real-time here ...
Divis Laboratories Ltd is quoting at Rs 6125.5, down 1.77% on the day as on 13:19 IST on the NSE. The stock jumped 2.08% in last one year as compared to a 9.4% rally in NIFTY and a 0.15% fall in the ...
Earnings call Divi's Laboratories reported a 17% YoY revenue growth in Q2 FY26, driven by a record 56% contribution from custom synthesis. Margins remained resilient despite ongoing generic pricing ...
Hosted on MSN
Stock Picks: Sagar Doshi suggests Divis Lab, HCL Tech, Marico shares to buy amid Indo-Pak conflict
Stock market today: Indian stock markets initially opened lower but then bounced back, trading flat at the time of this report on Wednesday following India’s anti ...
Divi’s Laboratories’ (Divi’s) Q2FY26 result was in line with our expectations on all fronts. Constant currency growth slowed down to ~10.8% vs. 15% QoQ and 18% in FY25. Q2 growth was largely led by ...
Divi’s Laboratories (DIVI) Q2FY26 EBITDA was a beat; 7% above our estimates led by higher CS revenues. We expect margins to improve, led by better product mix and stable raw material prices. Mgmt.
Murali Krishna Divi Chairman and managing director, Divis Laboratories Age: 63 Rank in the Rich List: 45 Net Worth: $2.03 billion The Big Challenge Faced in the Last Year: Managing growth in an ...
Amid the rising volatility in the Indian equity markets, domestic brokerage firm BP Equities has shared its top picks for January 2026 on a techno-funda basis. These include names like Bharat ...
BRIEF-Divis Laboratories says USFDA inspection done without any observations for unit-I at Hyderabad
Divis Laboratories Ltd has informed BSE that it has had a successful inspection by the US-FDA from 16th to 20th June, 2014, without any observations, for its Unit-I at vill. Lingojigudem, Choutuppal ...
On June 6, Divis Laboratories releases figures for Q4. Wall Street analysts expect Divis Laboratories will be reporting earnings per share of INR 14.95. Follow Divis Laboratories stock price in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results